Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxwell M Chait

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
World Journal of Gastrointestinal Endoscopy|December 17, 2010
Lower gastrointestinal bleeding in the elderlyMaxwell M Chait
World Journal of Gastrointestinal Endoscopy|December 31, 2010
Gastroesophageal reflux disease: Important considerations for the older patientsMaxwell M Chait
Clinical and Experimental Gastroenterology|April 3, 2018
Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutionsJoseph Mermelstein, Alanna Chait Mermelstein, Maxwell M Chait
Clinical and Experimental Gastroenterology|July 30, 2016
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazoleJoseph Mermelstein, Alanna Chait Mermelstein, Maxwell M Chait
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
World Journal of Gastrointestinal Endoscopy|December 17, 2010
Lower gastrointestinal bleeding in the elderlyMaxwell M Chait
World Journal of Gastrointestinal Endoscopy|December 31, 2010
Gastroesophageal reflux disease: Important considerations for the older patientsMaxwell M Chait
Clinical and Experimental Gastroenterology|April 3, 2018
Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutionsJoseph Mermelstein, Alanna Chait Mermelstein, Maxwell M Chait
Clinical and Experimental Gastroenterology|July 30, 2016
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazoleJoseph Mermelstein, Alanna Chait Mermelstein, Maxwell M Chait
Pageof 1